Bafna Pharmaceuticals Limited Capital Reinvestment Ratio
Bafna Pharmaceuticals Limited capital reinvestment ratio. Bafna Pharmaceuticals Limited (BAFNAPH) has a Capital Reinvestment Ratio of 1.76x as of September 2025, meaning it reinvests 2% of its operating cash flow (Rs93.12 Million) in capital expenditures (Rs164.17 Million). See free cash flow generation of Bafna Pharmaceuticals Limited to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bafna Pharmaceuticals Limited (2007–2026)
Capital reinvestment ratio of Bafna Pharmaceuticals Limited from 2007 to 2026. This chart tracks Bafna Pharmaceuticals Limited's Capital Reinvestment Ratio across 10 annual periods. See financial flexibility index of Bafna Pharmaceuticals Limited to measure the company's free cash flow as a share of total liabilities.
Bafna Pharmaceuticals Limited Capital Reinvestment Ratio by Year (2007–2026)
Bafna Pharmaceuticals Limited capital reinvestment ratio by year from 2007 to 2026. For the full cash flow conversion analysis, see Bafna Pharmaceuticals Limited operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 2.11x | Rs118.27 Million | Rs249.03 Million | ▲ +88.1% |
| 2025 | 1.12x | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 1.64x | Rs94.85 Million | Rs155.78 Million | ▼ -1.0% |
| 2023 | 1.66x | Rs49.52 Million | Rs82.19 Million | ▲ +114.1% |
| 2022 | 0.78x | Rs97.28 Million | Rs75.41 Million | ▼ -69.4% |
| 2016 | 2.53x | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs101.06 Million | Rs187.01 Million | — |